These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene expression profiling of primary cutaneous melanoma and clinical outcome. Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A; J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783 [TBL] [Abstract][Full Text] [Related]
5. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma. Ferrari D; Lombardi M; Ricci R; Michiara M; Santini M; De Panfilis G J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918 [TBL] [Abstract][Full Text] [Related]
6. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
7. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007 [TBL] [Abstract][Full Text] [Related]
8. [Molecular markers associated to prognosis of melanoma]. Heenen M; Laporte M Ann Dermatol Venereol; 2003 Nov; 130(11):1025-31. PubMed ID: 14724537 [TBL] [Abstract][Full Text] [Related]
9. The role of RhoC in growth and metastatic capacity of melanoma. Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696 [TBL] [Abstract][Full Text] [Related]
10. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related]
11. Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics. Goldmann T; Ribbert D; Suter L; Brode M; Otto F J Exp Clin Cancer Res; 1998 Dec; 17(4):483-9. PubMed ID: 10089072 [TBL] [Abstract][Full Text] [Related]
12. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract. Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597 [TBL] [Abstract][Full Text] [Related]
13. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy. Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions. Seregard S; Oskarsson M; Spângberg B Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396 [TBL] [Abstract][Full Text] [Related]
15. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
16. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264 [TBL] [Abstract][Full Text] [Related]
17. Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma. Döme B; Somlai B; Ladányi A; Fazekas K; Zöller M; Tímár J Virchows Arch; 2001 Nov; 439(5):628-35. PubMed ID: 11764382 [TBL] [Abstract][Full Text] [Related]
18. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma. Thies A; Schachner M; Berger J; Moll I; Schulze HJ; Brunner G; Schumacher U J Pathol; 2004 Aug; 203(4):933-9. PubMed ID: 15258996 [TBL] [Abstract][Full Text] [Related]
19. Relationship of nm23 expression to proliferation and prognosis in malignant melanomas of the oral cavity. Korabiowska M; Hönig JF; Jawien J; Knapik J; Stachura J; Cordon-Cardo C; Fischer G In Vivo; 2005; 19(6):1093-6. PubMed ID: 16277028 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]